Table 1 Baseline characteristics

Age, M (Q₁, Q₃)

66.00 (57.00, 73.00)

69.00 (62.00,74.00)

66.00 (58.00,73.00)

64.00 (55.00,71.00)

χ²=251.35

< 0.001

Bmi, M (Q₁, Q₃)

25.73 (24.22, 27.68)

24.96 (22.99,27.34)

25.25 (22.96,27.34)

26.12 (24.82,27.77)

χ²=262.30

< 0.001

HCY, M (Q₁, Q₃)

11.63 (7.73, 15.84)

13.06 (9.07,17.93)

11.43 (7.16,15.82)

10.76 (6.86,14.51)

χ²=199.13

< 0.001

D-Dimer, M (Q₁, Q₃)

0.34 (0.22, 0.46)

0.35 (0.22,0.48)

0.35 (0.21,0.49)

0.34 (0.22,0.45)

χ²=10.33

0.006

FIB, M (Q₁, Q₃)

3.00 (2.02, 4.02)

3.04 (2.04,4.02)

2.97 (2.14,4.08)

2.98 (1.99,4.02)

χ²=0.43

0.808

CR, M (Q₁, Q₃)

72.00 (54.00, 89.00)

72.00 (54.00,89.00)

69.00 (53.00,85.00)

72.00 (54.00,90.00)

χ²=6.91

0.032

BUA, M (Q₁, Q₃)

328.00 (218.00, 447.00)

282.00 (182.00,374.00)

451.00 (414.00,480.50)

341.00 (235.00,501.00)

χ²=654.31

< 0.001

ApoA, M (Q₁, Q₃)

1.40 (1.25, 1.55)

1.41 (1.25,1.56)

1.39 (1.26,1.56)

1.39 (1.25,1.55)

χ²=0.21

0.900

ApoB, M (Q₁, Q₃)

1.00 (0.85, 1.15)

0.99 (0.84,1.14)

0.99 (0.85,1.15)

1.01 (0.85,1.16)

χ²=3.04

0.219

Apo a, M (Q₁, Q₃)

250.00 (173.75, 365.25)

214.00 (107.00,307.75)

266.00 (206.00,360.50)

268.00 (206.00,412.00)

χ²=262.35

< 0.001

Hscrp, M (Q₁, Q₃)

1.63 (0.92, 2.32)

1.63 (0.94,2.32)

1.57 (0.90,2.21)

1.63 (0.91,2.33)

χ²=1.23

0.541

Grade, n(%)

χ²=298.66

< 0.001

low-risk

4227 (72.68)

1368 (60.58)

317 (79.45)

2542 (80.47)

moderate-risk

1066 (18.33)

550 (24.36)

60 (15.04)

456 (14.43)

high-risk

523 (8.99)

340 (15.06)

22 (5.51)

161 (5.10)

Sex, n(%)

χ²=6.09

0.048

   Male

3388 (58.25)

1358 (60.14)

220 (55.14)

1810 (57.30)

   Female

2428 (41.75)

900 (39.86)

179 (44.86)

1349 (42.70)

HTN, n(%)

χ²=72.60

< 0.001

 None

2271 (39.05)

729 (32.29)

161 (40.35)

1381 (43.72)

 Yes

3545 (60.95)

1529 (67.71)

238 (59.65)

1778 (56.28)

Drink, n(%)

χ²=3.59

0.166

 None

5058 (86.97)

1941 (85.96)

353 (88.47)

2764 (87.50)

 Yes

758 (13.03)

317 (14.04)

46 (11.53)

395 (12.50)

Smoke, n(%)

χ²=163.27

< 0.001

 None

4487 (77.15)

1543 (68.33)

324 (81.20)

2620 (82.94)

 Yes

1329 (22.85)

715 (31.67)

75 (18.80)

539 (17.06)

DM, n(%)

χ²=475.94

< 0.001

 None

4028 (69.26)

1192 (52.79)

297 (74.44)

2539 (80.37)

 Yes

1788 (30.74)

1066 (47.21)

102 (25.56)

620 (19.63)

Stroke, n(%)

χ²=101.20

< 0.001

 None

3915 (67.31)

1376 (60.94)

234 (58.65)

2305 (72.97)

 Yes

1901 (32.69)

882 (39.06)

165 (41.35)

854 (27.03)

ICA, n(%)

χ²=425.46

< 0.001

 None

3956 (68.02)

1212 (53.68)

231 (57.89)

2513 (79.55)

 Yes

1860 (31.98)

1046 (46.32)

168 (42.11)

646 (20.45)

PVD, n(%)

χ²=2.28

0.320

 None

5740 (98.69)

2224 (98.49)

392 (98.25)

3124 (98.89)

 Yes

76 (1.31)

34 (1.51)

7 (1.75)

35 (1.11)

HLP, n(%)

χ²=673.66

< 0.001

 None

1960 (33.70)

1210 (53.59)

44 (11.03)

706 (22.35)

 Yes

3856 (66.30)

1048 (46.41)

355 (88.97)

2453 (77.65)

Glucose Control, n(%)

χ²=143.19

< 0.001

 None

3906 (67.16)

1311 (58.06)

272 (68.17)

2323 (73.54)

 Yes

1910 (32.84)

947 (41.94)

127 (31.83)

836 (26.46)